Small, multiplex, traceable.
The ALiA® SARS-CoV-2 Antigen FIA Test employs a unique immunofluorescent-based BioChip with our advanced microfluidic and microarray technologies for the qualitative detection of nucleocapsid protein from SARS-CoV-2. The ALiA® SARS-CoV-2 Antigen FIA Test delivers a 20-minute result of direct nasopharyngeal swab from COVID-19 suspected patient with symptoms onset within 14 days.
A microscopic test site used to capture molecules and perform multiplex immunoassays.
We use the high accuracy of florescent immunoassay to produce test results.
Safe & Easy to Use
Weighing only 5 kgs and equipped with an easy-to-use GUI, ALiA is operable by any personnell with minimal training.
Traceable BioChips allow us to track product cycles and identify counterfeits.
React ∘ Respond ∘ Reconnect
Our Diagnosis Panels
With the flexibility of microarray technology, we have developed a single test for COVID-19, duplex for FluA and FluB, quadruplex (4-in-1) for FluA, FluB, RSV, HAdV, and 5-in-1 for FluA, FluB, RSV, HAdV, COVID-19, to offer the most appropriate support to medical professionals at the frontline.
3 SIMPLE STEPS
It's that easy.
1. Load sample into BioChip
2. Insert into the tray and enter ID
3. Read the results and print